| E-Y0001722 |
EP |
|
Rosuvastatin impurity G |
|
0.004 mg |
1264 |
42 |
| E-Y0001721 |
EP |
|
Rosuvastatin for system suitability |
|
15 mg |
1264 |
28 |
| E-Y0001720 |
EP |
【羥基丙基纖維素（訂 |
Hydroxypropylce丨丨ulose |
|
150 mg |
1264 |
28 |
| E-Y0001719 |
EP |
|
Rosuvastatin Calcium |
|
100 mg |
1264 |
28 |
| E-Y0001718 |
EP |
|
Drospirenone for peak identification |
|
10 mg |
1264 |
28 |
| E-Y0001717 |
EP |
【豬胰島素系統(tǒng)適應(yīng) |
Insulin porcine for system suitability |
|
9 mg |
1484.59 |
42 |
| E-Y0001716 |
EP |
【卡比多巴雜質(zhì)混合 |
Carbidopa impurity mixture |
|
0.008 mg |
1264 |
28 |
| E-Y0001715 |
EP |
【扎那米韋水合物（訂 |
Zanamivir hydrate |
|
5 mg |
1264 |
28 |
| E-Y0001714 |
EP |
【多西環(huán)素的系統(tǒng)適 |
Doxycycline for system suitability |
|
10 mg |
1264 |
28 |
| E-Y0001713 |
EP |
【卡比多巴系統(tǒng)適應(yīng) |
Carbidopa for system suitability |
|
10 mg |
1264 |
28 |
| E-Y0001712 |
EP |
|
Polyoxypropylene stearyl ether |
|
250 mg |
1264 |
28 |
| E-Y0001711 |
EP |
|
Fluocinolone acetonide for peak identification |
|
10 mg |
1264 |
28 |
| E-Y0001710 |
EP |
|
Fluocinolone acetonide for system suitability |
|
10 mg |
1264 |
28 |
| E-Y0001709 |
EP |
|
Lisinopril for system suitability A |
|
10 mg |
1264 |
28 |
| E-Y0001708 |
EP |
|
Zanamivir for system suitability |
|
10 mg |
1264 |
28 |
粵公網(wǎng)安備 44010302000979號
